{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:22:22Z","timestamp":1785252142039,"version":"3.55.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82360593"],"award-info":[{"award-number":["No. 82360593"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82260714"],"award-info":[{"award-number":["No. 82260714"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joint Project on Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation","award":["No. 2023GXNSFAA026133"],"award-info":[{"award-number":["No. 2023GXNSFAA026133"]}]},{"name":"First-class Discipline Innovation-Driven Talent Program of Guangxi Medical University"},{"name":"Graduate Innovation Project of Biomedical Engineering at Guangxi Medical University","award":["SG 202409"],"award-info":[{"award-number":["SG 202409"]}]},{"name":"\u201cFuture Academic Star\u201d Fund of Guangxi Medical University","award":["WLXSZX24088"],"award-info":[{"award-number":["WLXSZX24088"]}]},{"name":"Training Program for Thousands of Young and Middle-Aged Key Teachers in Guangxi Higher Education Institutions and Guangxi Bagui Outstanding Young Scholars Program"},{"name":"the Middle \/ Young aged Teachers' Research Ability Improvement Project of Guangxi Higher Education","award":["2023KY0098"],"award-info":[{"award-number":["2023KY0098"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-026-02007-y","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:47:45Z","timestamp":1770817665000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mechanistic insights into a novel GPX4 inhibitor Compound AI-3p reversing cisplatin-resistance in ovarian cancer cells"],"prefix":"10.1186","volume":"19","author":[{"given":"Bingyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linfang","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-an","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingzhen","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaxin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0969-7014","authenticated-orcid":false,"given":"Chunmiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"2007_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03826-w","volume":"23","author":"J Hillmann","year":"2025","unstructured":"Hillmann J, Maass N, Bauerschlag DO, Fl\u00f6rkemeier I. Promising new drugs and therapeutic approaches for treatment of ovarian cancer-targeting the hallmarks of cancer. BMC Med. 2025;23:10. https:\/\/doi.org\/10.1186\/s12916-024-03826-w.","journal-title":"BMC Med"},{"key":"2007_CR2","unstructured":"Ferlay J, et al. Global cancer observatory: cancer today. Lyon, France: International agency for research on cancer; 2024. https:\/\/gco.iarc.who.int\/today."},{"key":"2007_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ph17060778","author":"D Luvero","year":"2024","unstructured":"Luvero D. Tailored treatment strategies in first line therapy for ovarian cancer patients: a critical review of the literature. Pharmaceuticals (Basel). 2024. https:\/\/doi.org\/10.3390\/ph17060778.","journal-title":"Pharmaceuticals (Basel)"},{"key":"2007_CR4","doi-asserted-by":"publisher","DOI":"10.3892\/or.2022.8293","author":"L Yang","year":"2022","unstructured":"Yang L. Molecular mechanisms of platinum\u2011based chemotherapy resistance in ovarian cancer (Review). Oncol Rep. 2022. https:\/\/doi.org\/10.3892\/or.2022.8293.","journal-title":"Oncol Rep"},{"key":"2007_CR5","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.jconrel.2023.03.017","volume":"356","author":"X Liang","year":"2023","unstructured":"Liang X, et al. cRGD-targeted heparin nanoparticles for effective dual drug treatment of cisplatin-resistant ovarian cancer. J Control Release. 2023;356:691\u2013701. https:\/\/doi.org\/10.1016\/j.jconrel.2023.03.017.","journal-title":"J Control Release"},{"key":"2007_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114205","volume":"232","author":"M Song","year":"2022","unstructured":"Song M, Cui M, Liu K. Therapeutic strategies to overcome cisplatin resistance in ovarian cancer. Eur J Med Chem. 2022;232:114205. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114205.","journal-title":"Eur J Med Chem"},{"key":"2007_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0720-y","volume":"12","author":"Y Mou","year":"2019","unstructured":"Mou Y, et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019;12:34. https:\/\/doi.org\/10.1186\/s13045-019-0720-y.","journal-title":"J Hematol Oncol"},{"key":"2007_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11:88. https:\/\/doi.org\/10.1038\/s41419-020-2298-2.","journal-title":"Cell Death Dis"},{"key":"2007_CR9","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.240151","volume":"15","author":"S Miglietta","year":"2025","unstructured":"Miglietta S, et al. Mitochondrial chaperonin DNAJC15 promotes vulnerability to ferroptosis of chemoresistant ovarian cancer cells. Open Biol. 2025;15:240151. https:\/\/doi.org\/10.1098\/rsob.240151.","journal-title":"Open Biol"},{"key":"2007_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154701","volume":"112","author":"M Ni","year":"2023","unstructured":"Ni M, et al. Shikonin and cisplatin synergistically overcome cisplatin resistance of ovarian cancer by inducing ferroptosis via upregulation of HMOX1 to promote Fe(2+) accumulation. Phytomedicine. 2023;112:154701. https:\/\/doi.org\/10.1016\/j.phymed.2023.154701.","journal-title":"Phytomedicine"},{"key":"2007_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","volume":"26","author":"WS Yang","year":"2016","unstructured":"Yang WS, Stockwell BR. Ferroptosis: death by lipid peroxidation. Trends Cell Biol. 2016;26:165\u201376. https:\/\/doi.org\/10.1016\/j.tcb.2015.10.014.","journal-title":"Trends Cell Biol"},{"key":"2007_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1269451","volume":"14","author":"XD Zhang","year":"2023","unstructured":"Zhang XD, et al. Mechanisms and regulations of ferroptosis. Front Immunol. 2023;14:1269451. https:\/\/doi.org\/10.3389\/fimmu.2023.1269451.","journal-title":"Front Immunol"},{"key":"2007_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer MJ, et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature. 2017;551:247\u201350. https:\/\/doi.org\/10.1038\/nature24297.","journal-title":"Nature"},{"key":"2007_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116680","volume":"175","author":"W Guo","year":"2024","unstructured":"Guo W, et al. Angelica sinensis polysaccharide combined with cisplatin reverses cisplatin resistance of ovarian cancer by inducing ferroptosis via regulating GPX4. Biomed Pharmacother. 2024;175:116680. https:\/\/doi.org\/10.1016\/j.biopha.2024.116680.","journal-title":"Biomed Pharmacother"},{"key":"2007_CR15","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1080\/15548627.2023.2218764","volume":"19","author":"Y Xie","year":"2023","unstructured":"Xie Y, Kang R, Klionsky DJ, Tang D. GPX4 in cell death, autophagy, and disease. Autophagy. 2023;19:2621\u201338. https:\/\/doi.org\/10.1080\/15548627.2023.2218764.","journal-title":"Autophagy"},{"key":"2007_CR16","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41589-020-0501-5","volume":"16","author":"JK Eaton","year":"2020","unstructured":"Eaton JK, et al. Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles. Nat Chem Biol. 2020;16:497\u2013506. https:\/\/doi.org\/10.1038\/s41589-020-0501-5.","journal-title":"Nat Chem Biol"},{"key":"2007_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59081448","author":"W Huang","year":"2023","unstructured":"Huang W. Network pharmacology and molecular docking analysis exploring the mechanism of Tripterygium wilfordii in the treatment of oral lichen planus. Medicina Kaunas. 2023. https:\/\/doi.org\/10.3390\/medicina59081448.","journal-title":"Medicina Kaunas"},{"key":"2007_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4599305","volume":"2022","author":"C Li","year":"2022","unstructured":"Li C, et al. Identification of biomarkers associated with cancerous change in oral leukoplakia based on integrated transcriptome analysis. J Oncol. 2022;2022:4599305. https:\/\/doi.org\/10.1155\/2022\/4599305.","journal-title":"J Oncol"},{"key":"2007_CR19","doi-asserted-by":"publisher","DOI":"10.1063\/1.5100601","volume":"150","author":"MAF Dos Santos","year":"2019","unstructured":"Dos Santos MAF, et al. Dynamical aspects of supercooled TIP3P-water in the grooves of DNA. J Chem Phys. 2019;150:235101. https:\/\/doi.org\/10.1063\/1.5100601.","journal-title":"J Chem Phys"},{"key":"2007_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118107","volume":"329","author":"Y Li","year":"2024","unstructured":"Li Y, et al. Paeonia lactiflora Pall. ameliorates acetaminophen-induced oxidative stress and apoptosis via inhibiting the PKC-ERK pathway. J Ethnopharmacol. 2024;329:118107. https:\/\/doi.org\/10.1016\/j.jep.2024.118107.","journal-title":"J Ethnopharmacol"},{"key":"2007_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13030311","author":"D Rand","year":"2021","unstructured":"Rand D. Endothelial iron homeostasis regulates blood-brain barrier integrity via the HIF2\u03b1-Ve-Cadherin pathway. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13030311.","journal-title":"Pharmaceutics"},{"key":"2007_CR22","doi-asserted-by":"publisher","DOI":"10.1101\/2025.03.24.644978","author":"M Ramesh","year":"2025","unstructured":"Ramesh M, Govindaraju T. Mir-7a-Klf4 axis as a regulator and therapeutic target of neuroinflammation and ferroptosis in Alzheimer\u2019s disease. BioRxiv. 2025. https:\/\/doi.org\/10.1101\/2025.03.24.644978.","journal-title":"BioRxiv"},{"key":"2007_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103302","volume":"75","author":"B Sun","year":"2024","unstructured":"Sun B, et al. FDX1 downregulation activates mitophagy and the PI3K\/AKT signaling pathway to promote hepatocellular carcinoma progression by inducing ROS production. Redox Biol. 2024;75:103302. https:\/\/doi.org\/10.1016\/j.redox.2024.103302.","journal-title":"Redox Biol"},{"key":"2007_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-94868-4","volume":"15","author":"Q Gao","year":"2025","unstructured":"Gao Q, et al. Microsecond pulsed electric fields induce myocardial ablation by secondary mitochondrial damage and cell death mechanisms. Sci Rep. 2025;15:10132. https:\/\/doi.org\/10.1038\/s41598-025-94868-4.","journal-title":"Sci Rep"},{"key":"2007_CR25","doi-asserted-by":"publisher","first-page":"17993","DOI":"10.1021\/acsomega.0c01256","volume":"5","author":"V Gorki","year":"2020","unstructured":"Gorki V, et al. \u03b2-Carboline derivatives tackling malaria: biological evaluation and docking analysis. ACS Omega. 2020;5:17993\u20138006. https:\/\/doi.org\/10.1021\/acsomega.0c01256.","journal-title":"ACS Omega"},{"key":"2007_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ph15101245","author":"MM Fakhry","year":"2022","unstructured":"Fakhry MM. Rational design, synthesis and biological evaluation of novel pyrazoline-based antiproliferative agents in MCF-7 cancer cells. Pharmaceuticals (Basel). 2022. https:\/\/doi.org\/10.3390\/ph15101245.","journal-title":"Pharmaceuticals (Basel)"},{"key":"2007_CR27","doi-asserted-by":"publisher","first-page":"2444311","DOI":"10.1080\/15592324.2024.2444311","volume":"20","author":"R Guir\u00e9","year":"2025","unstructured":"Guir\u00e9 R, et al. The inhibitory activities of two compounds from securidaca longepedunculata Fresen on the acetylcholinesterase from wheat pest schizaphis Graminum rondani: in Silico analysis. Plant Signal Behav. 2025;20:2444311. https:\/\/doi.org\/10.1080\/15592324.2024.2444311.","journal-title":"Plant Signal Behav"},{"key":"2007_CR28","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1134\/S0026893308040195","volume":"42","author":"M Lobanov","year":"2008","unstructured":"Lobanov M, Bogatyreva NS, Galzitskaia OV. [Radius of gyration is indicator of compactness of protein structure]. Mol Biol (Mosk). 2008;42:701\u20136.","journal-title":"Mol Biol (Mosk)"},{"key":"2007_CR29","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1021\/j100854a047","volume":"72","author":"LS Baskin","year":"1968","unstructured":"Baskin LS. Electric conductance and pH measurements of isoionic salt-free bovine mercaptalbumin solutions. An evaluation of root-mean-square proton fluctuations. J Phys Chem. 1968;72:2958\u201362. https:\/\/doi.org\/10.1021\/j100854a047.","journal-title":"J Phys Chem"},{"key":"2007_CR30","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2024.2447719","volume":"40","author":"NV Phong","year":"2025","unstructured":"Phong NV, Kim HS, Zhao Y, Yeom E, Yang SY. Indirubin-3\u2019-oxime as a dual-action agent: mitigating heat-induced male infertility in Drosophila melanogaster and inhibiting soluble epoxide hydrolase. J Enzyme Inhib Med Chem. 2025;40:2447719. https:\/\/doi.org\/10.1080\/14756366.2024.2447719.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"2007_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.920059","volume":"13","author":"C Zhang","year":"2022","unstructured":"Zhang C, Liu N. Ferroptosis, necroptosis, and pyroptosis in the occurrence and development of ovarian cancer. Front Immunol. 2022;13:920059. https:\/\/doi.org\/10.3389\/fimmu.2022.920059.","journal-title":"Front Immunol"},{"key":"2007_CR32","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042.","journal-title":"Cell"},{"key":"2007_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188890","volume":"1878","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wan Y, Jiang Y, Zhang L, Cheng W. GPX4: the hub of lipid oxidation, ferroptosis, disease and treatment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2023;1878:188890. https:\/\/doi.org\/10.1016\/j.bbcan.2023.188890.","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"key":"2007_CR34","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3390\/antiox14050527","volume":"14","author":"N Abdukarimov","year":"2025","unstructured":"Abdukarimov N, Kokabi K, Kunz J. Ferroptosis and iron homeostasis: molecular mechanisms and neurodegenerative disease implications. Antioxidants. 2025;14:527.","journal-title":"Antioxidants"},{"key":"2007_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-025-01514-7","author":"Y Qiu","year":"2025","unstructured":"Qiu Y, et al. Interplay of ferroptotic and apoptotic cell death and its modulation by BH3-mimetics. Cell Death Differ. 2025. https:\/\/doi.org\/10.1038\/s41418-025-01514-7.","journal-title":"Cell Death Differ"},{"key":"2007_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02654-y","volume":"11","author":"S Chang","year":"2025","unstructured":"Chang S, et al. Redox mechanism of glycerophospholipids and relevant targeted therapy in ferroptosis. Cell Death Discov. 2025;11:358. https:\/\/doi.org\/10.1038\/s41420-025-02654-y.","journal-title":"Cell Death Discov"},{"key":"2007_CR37","doi-asserted-by":"publisher","first-page":"880","DOI":"10.17179\/excli2025-8449","volume":"24","author":"K Jomova","year":"2025","unstructured":"Jomova K, et al. The role of redox-active iron, copper, manganese, and redox-inactive zinc in toxicity, oxidative stress, and human diseases. Excli J. 2025;24:880\u2013954. https:\/\/doi.org\/10.17179\/excli2025-8449.","journal-title":"Excli J"},{"key":"2007_CR38","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1016\/j.bbagen.2012.11.020","volume":"1830","author":"R Brigelius-Floh\u00e9","year":"2013","unstructured":"Brigelius-Floh\u00e9 R, Maiorino M. Glutathione peroxidases. Biochim Biophys Acta. 2013;1830:3289\u2013303. https:\/\/doi.org\/10.1016\/j.bbagen.2012.11.020.","journal-title":"Biochim Biophys Acta"},{"key":"2007_CR39","doi-asserted-by":"publisher","first-page":"863","DOI":"10.32604\/or.2024.054201","volume":"33","author":"J Wei","year":"2025","unstructured":"Wei J, Zhu L. The role of glutathione peroxidase 4 in the progression, drug resistance, and targeted therapy of non-small cell lung cancer. Oncol Res. 2025;33:863\u201372. https:\/\/doi.org\/10.32604\/or.2024.054201.","journal-title":"Oncol Res"},{"key":"2007_CR40","doi-asserted-by":"publisher","DOI":"10.4081\/ejh.2015.2540","volume":"59","author":"E Guerriero","year":"2015","unstructured":"Guerriero E, et al. GPX4 and GPX7 over-expression in human hepatocellular carcinoma tissues. Eur J Histochem. 2015;59:2540. https:\/\/doi.org\/10.4081\/ejh.2015.2540.","journal-title":"Eur J Histochem"},{"key":"2007_CR41","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.2147\/cmar.S163432","volume":"10","author":"K Liu","year":"2018","unstructured":"Liu K, Jin M, Xiao L, Liu H, Wei S. Distinct prognostic values of mRNA expression of glutathione peroxidases in non-small cell lung cancer. Cancer Manag Res. 2018;10:2997\u20133005. https:\/\/doi.org\/10.2147\/cmar.S163432.","journal-title":"Cancer Manag Res"},{"key":"2007_CR42","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41374-017-0008-1","volume":"98","author":"Y Kinowaki","year":"2018","unstructured":"Kinowaki Y, et al. Glutathione peroxidase 4 overexpression inhibits ROS-induced cell death in diffuse large B-cell lymphoma. Lab Invest. 2018;98:609\u201319. https:\/\/doi.org\/10.1038\/s41374-017-0008-1.","journal-title":"Lab Invest"},{"key":"2007_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.913669","volume":"12","author":"X Zhang","year":"2022","unstructured":"Zhang X, et al. Glutathione peroxidase 4 as a therapeutic target for anti-colorectal cancer drug-tolerant persister cells. Front Oncol. 2022;12:913669. https:\/\/doi.org\/10.3389\/fonc.2022.913669.","journal-title":"Front Oncol"},{"key":"2007_CR44","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/1471-0528.17327","volume":"129","author":"X Wu","year":"2022","unstructured":"Wu X, et al. High co-expression of SLC7A11 and GPX4 as a predictor of platinum resistance and poor prognosis in patients with epithelial ovarian cancer. BJOG. 2022;129:40\u20139. https:\/\/doi.org\/10.1111\/1471-0528.17327.","journal-title":"BJOG"},{"key":"2007_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01606-1","volume":"8","author":"S Sun","year":"2023","unstructured":"Sun S, Shen J, Jiang J, Wang F, Min J. Targeting ferroptosis opens new avenues for the development of novel therapeutics. Signal Transduct Target Ther. 2023;8:372. https:\/\/doi.org\/10.1038\/s41392-023-01606-1.","journal-title":"Signal Transduct Target Ther"},{"key":"2007_CR46","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1016\/j.bmc.2018.05.013","volume":"26","author":"J Zhu","year":"2018","unstructured":"Zhu J, Mo J, Lin HZ, Chen Y, Sun HP. The recent progress of isoxazole in medicinal chemistry. Bioorg Med Chem. 2018;26:3065\u201375. https:\/\/doi.org\/10.1016\/j.bmc.2018.05.013.","journal-title":"Bioorg Med Chem"},{"key":"2007_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113359","volume":"217","author":"SJ Liu","year":"2021","unstructured":"Liu SJ, et al. Design, synthesis, and biological evaluation of nitroisoxazole-containing spiro[pyrrolidin-oxindole] derivatives as novel glutathione peroxidase 4\/mouse double minute 2 dual inhibitors that inhibit breast adenocarcinoma cell proliferation. Eur J Med Chem. 2021;217:113359. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113359.","journal-title":"Eur J Med Chem"},{"key":"2007_CR48","doi-asserted-by":"publisher","first-page":"7038","DOI":"10.1111\/febs.16059","volume":"289","author":"J Liu","year":"2022","unstructured":"Liu J, Kang R, Tang D. Signaling pathways and defense mechanisms of ferroptosis. FEBS J. 2022;289:7038\u201350. https:\/\/doi.org\/10.1111\/febs.16059.","journal-title":"FEBS J"},{"key":"2007_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101107","volume":"23","author":"M Dodson","year":"2019","unstructured":"Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 2019;23:101107. https:\/\/doi.org\/10.1016\/j.redox.2019.101107.","journal-title":"Redox Biol"},{"key":"2007_CR50","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12:599\u2013620. https:\/\/doi.org\/10.1007\/s13238-020-00789-5.","journal-title":"Protein Cell"},{"key":"2007_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44228-5","volume":"14","author":"LK Chu","year":"2023","unstructured":"Chu LK, et al. Autophagy of OTUD5 destabilizes GPX4 to confer ferroptosis-dependent kidney injury. Nat Commun. 2023;14:8393. https:\/\/doi.org\/10.1038\/s41467-023-44228-5.","journal-title":"Nat Commun"},{"key":"2007_CR52","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1007\/s10753-024-02137-9","volume":"48","author":"LM Zhang","year":"2025","unstructured":"Zhang LM, et al. FBXW7-Mediated downregulation of GPX4 aggravates acute kidney injury following Ischemia\u2013Reperfusion. Inflammation. 2025;48:1484\u201398. https:\/\/doi.org\/10.1007\/s10753-024-02137-9.","journal-title":"Inflammation"},{"key":"2007_CR53","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1021\/acsmedchemlett.3c00571","volume":"15","author":"M Hu","year":"2024","unstructured":"Hu M, et al. ZX703: a small-molecule degrader of GPX4 inducing ferroptosis in human cancer cells. ACS Med Chem Lett. 2024;15:406\u201312. https:\/\/doi.org\/10.1021\/acsmedchemlett.3c00571.","journal-title":"ACS Med Chem Lett"},{"key":"2007_CR54","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao C, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature. 2021;593:586\u201390. https:\/\/doi.org\/10.1038\/s41586-021-03539-7.","journal-title":"Nature"},{"key":"2007_CR55","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll S, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575:693\u20138. https:\/\/doi.org\/10.1038\/s41586-019-1707-0.","journal-title":"Nature"},{"key":"2007_CR56","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575:688\u201392. https:\/\/doi.org\/10.1038\/s41586-019-1705-2.","journal-title":"Nature"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-026-02007-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02007-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02007-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:03:54Z","timestamp":1773795834000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-026-02007-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2007"],"URL":"https:\/\/doi.org\/10.1186\/s13048-026-02007-y","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"9 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"104"}}